D3 BIO Trademark

Trademark Overview


On Thursday, April 22, 2021, a trademark application was filed for D3 BIO with the United States Patent and Trademark Office. The USPTO has given the D3 BIO trademark a serial number of 90662890. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, September 19, 2024. This trademark is owned by D3 Bio (Wuxi) Co., Ltd.. The D3 BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug evaluation, namely, pharmaceutical product evaluation; pharmaceutical research; pharmaceutical drug development services; research services in the field of pharmaceutical drugs; scientific research for medical purposes in the field of cancer; biological research; scientific research in the nature of conducting clinical trials for others; medical research; research and development of antibodies; development of pharmaceutical preparations and pharmaceuticals; none of the foregoing in the field of radiation oncology
d3 bio

General Information


Serial Number90662890
Word MarkD3 BIO
Filing DateThursday, April 22, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Description of MarkThe mark consists of the words "D3 BIO" in black all caps below three Chinese characters in red, all to the right of a rounded red zig-zag design centered on a red vertical line.
NOT AVAILABLEThe non-Latin characters in the mark transliterate to "DeShengJi" and this means "Moral Rise Aid" in English.
Pseudo MarkD THREE BIO
Indication of Colors claimedThe color(s) red and black is/are claimed as a feature of the mark.
NOT AVAILABLE"BIO"
Goods and ServicesDrug evaluation, namely, pharmaceutical product evaluation; pharmaceutical research; pharmaceutical drug development services; research services in the field of pharmaceutical drugs; scientific research for medical purposes in the field of cancer; biological research; scientific research in the nature of conducting clinical trials for others; medical research; research and development of antibodies; development of pharmaceutical preparations and pharmaceuticals; none of the foregoing in the field of radiation oncology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 28, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameD3 Bio (Wuxi) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJiangsu Province 214100
CN

Party NameD3 Bio (Wuxi) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJiangsu Province 214100
CN

Trademark Events


Event DateEvent Description
Monday, April 26, 2021NEW APPLICATION ENTERED
Wednesday, July 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 29, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, December 17, 2021ASSIGNED TO EXAMINER
Wednesday, January 5, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 5, 2022NON-FINAL ACTION E-MAILED
Wednesday, January 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 23, 2022ASSIGNED TO LIE
Monday, July 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 7, 2024SOU EXTENSION 1 FILED
Thursday, March 7, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 7, 2024SOU EXTENSION 1 GRANTED
Friday, March 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 19, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 19, 2024SOU EXTENSION 2 FILED
Thursday, September 19, 2024SOU EXTENSION 2 GRANTED
Thursday, September 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 18, 2025TEAS DELETE 1(B) BASIS RECEIVED